Followers | 0 |
Posts | 1151 |
Boards Moderated | 0 |
Alias Born | 07/10/2003 |
Tuesday, August 03, 2004 3:34:50 PM
Baycol
On August 8, 2001, Bayer Pharmaceutical removed the cholesterol drug Baycol from the market after reports of at least 40 deaths linked to use of the drug. According to the Food and Drug Administration (FDA), Baycol has been linked to numerous fatal cases involving an adverse muscle reaction known as rhabdomyolysis.
Baycol (cerivastatin), which was initially approved in the U.S. in 1997, is a member of a class of cholesterol lowering drugs that are commonly referred to as "statins." Statins lower cholesterol levels by blocking a specific enzyme in the body that is involved in the synthesis of cholesterol. While all statins have been associated with very rare reports of rhabdomyolysis, cases of fatal rhabdomyolysis in association with the use of Baycol have been reported significantly more frequently than for other approved statins.
Fatal rhabdomyolysis reports with Baycol have been reported most frequently when used at higher doses, when used in elderly patients, and particularly, when used in combination with gemfibrozil (LOPID and generics), another lipid lowering drug. FDA has received reports of 31 U.S. deaths due to severe rhabdomyolysis associated with use of Baycol, 12 of which involved concomitant gemfibrozil use.
Rhabdomyolysis is a life threatening condition in which muscle cells breakdown and release the contents of the muscle into the blood stream. According to the FDA, symptoms of rhabdomyolysis include muscle pain, weakness, tenderness, fever, dark urine, nausea and vomiting. The lower back and calve areas are the most frequently impacted areas of the body. The FDA advises that in certain cases, the muscle injury is so severe that patients develop renal failure or other organ failure, which may be fatal.
700,000 Americans have taken Baycol. The FDA advises persons using Baycol to promptly consult their doctor.
Preserving Your Claim
All states have mandatory time limits in which lawsuits must be filed or claims may be forever barred. Persons believing they may have been injured by a recalled or dangerous drug and desiring to have a lawyer review their case may complete our online form or send us an email.
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM